Drug intelligence / Profile preview

2'-hydroxycinnamaldehyde

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

2'-Hydroxycinnamaldehyde (HCA) is a natural phenylpropanoid compound, mostly found in the bark of *Cinnamomum cassia* and in some other plants[9][1]. It has demonstrated anti-inflammatory and antitumor activities in various in vitro and in vivo models[9][7][10]. HCA exerts its primary effects by directly binding to and inhibiting the activation of the transcription factor STAT3 (signal transducer and activator of transcription 3), leading to reduced STAT3-driven gene transcription and inflammatory signaling[3][5][8][12]. In animal models, it has shown efficacy in alleviating colitis, psoriasiform skin lesions, myocardial ischemia/reperfusion injury, and cancer proliferation, with actions including modulation of tight junction proteins, suppression of pro-inflammatory cytokines, induction of apoptosis in cancer cells, disruption of mitochondrial function, generation of reactive oxygen species, and upregulation of cellular defense pathways (e.g., BAG3, Nrf2/HO-1)[3][5][7][9][10][12][13].

Other names
2-hydroxycinnamaldehyde(E)-3-(2-hydroxyphenyl)prop-2-enal3541-42-2CHEBI:178480CHemBL52569CHemBL-52569CHemBL 52569DTXSID601295133DTXSID-601295133DTXSID 601295133
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)PKM2 (Pyruvate kinase M2 isoform)

Beyond the preview

Go deeper on 2'-hydroxycinnamaldehyde.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-hydroxycinnamaldehyde.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call